Opioid G protein-coupled receptors: Signals at the crossroads of inflammation

Trends in Immunology

Volumn 24, Issue 3, 2003, Pages 116-121

  Rogers, Thomas J ^a   Peterson, Phillip K ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; OPIATE;

CELL ACTIVITY; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MACROPHAGE; MEDICAL RESEARCH; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; T LYMPHOCYTE;

EID: 0037373707     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00003-6     Document Type: Review

References (43)

1. Cantacuzene J. Nouvelles researches sur le mode de destruction des vibrions dans l'organisme. Ann. Inst. Pasteur Microbiol. 12:1898;273-300.
2. Shahabi N.A., et al. Murine splenocytes express a naloxone-insensitive binding site for β-endorphin. Endocrinology. 126:1990;1442-1448.
3. Bidlack J.M. Detection and function of opioid receptors on cells from the immune system. Clin. Diagn. Lab. Immunol. 7:2000;719-723.
4. Bohn L.M., et al. Mitogenic signaling via endogenous κ-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade. J. Neurochem. 74:2000;564-573.
5. Grimm M.C., et al. Opiates transdeactivate chemokine receptors: δ and μ opiate receptor-mediated heterologous desensitization. J. Exp. Med. 188:1998;317-325.
6. Gutstein H.B., et al. Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology. 87:1997;1118-1126.
7. Sharp B.M., et al. Detection of basal levels and induction of δ-opioid receptor mRNA in murine splenocytes. J. Neuroimmunol. 78:1997;198-202.
8. McCarthy L., et al. Opioids, opioid receptors and the immune response. Drug Alcohol Depend. 62:2001;111-123.
9. Wetzel M.A., et al. μ-opioid induction of monocyte chemoattractant protein-1, RANTES and IFN-γ-inducible protein-10 expression in human peripheral-blood mononuclear cells. J. Immunol. 165:2000;6519-6524.
10. Steele, A.D. et al. μ-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology. (in press).
11. Mahajan S.D., et al. Morphine regulates gene expression of α- and β-chemokines and their receptors on astroglial cells via the opioid μ receptor. J. Immunol. 169:2002;3589-3599.
12. + lymphocytes. Biochem. Pharmacol. 63:2002;1037-1041.
13. Sacerdote P., et al. Role of β-endorphin in the modulation of immune responses: perspectives in autoimmune diseases. Adv. Exp. Med. Biol. 63:2001;1037-1041.
14. Bajetto A., et al. Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 22:2001;147-184.
15. Chao C.C., et al. κ-opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8051-8056.
16. Chao C.C., et al. Activation of μ-opioid receptors inhibits microglial-cell chemotaxis. J. Pharmacol. Exp. Ther. 281:1997;998-1004.
17. Sheng W.S., et al. Immunomodulatory role of opioids in the central nervous system. Arch. Immunol. Ther. Exp. 45:1997;359-366.
18. Hu S., et al. Morphine inhibits human microglial cell production of, and migration towards, RANTES. J. Psychopharmacol. 14:2000;238-243.
19. Watkins L.R., et al. Glial activation: a driving force for pathological pain. Trends Neurosci. 24:2001;450-455.
20. Westmoreland S.V., et al. Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. J. Neuroimmunol. 122:2002;146-158.
21. Linner K.M., et al. Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J. Immunol. 154:1995;5049-5060.
22. Cabot P.J. Immune-derived opioids and peripheral antinociception. Clin. Exp. Pharmacol. Physiol. 28:2001;230-232.
23. Mousa S.A., et al. β-endorphin-containing memory-cells and μ-opioid receptors undergo transport to peripheral inflamed tissue. J. Neuroimmunol. 115:2001;71-78.
24. Mousa S.A., et al. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J. Neuroimmunol. 126:2002;5-15.
25. Cabot P.J., et al. Methionine-enkephalin-and dynorphin A-release from immune cells and control of inflammatory pain. Pain. 93:2001;207-212.
26. Machelska H., et al. Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J. Neurosci. 22:2002;5588-5596.
27. Ali H., et al. Chemoattractant receptor cross-desensitization. J. Biol. Chem. 274:1999;6027-6030.
28. Liu Y., et al. Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis. J. Pharmacol. Exp. Ther. 263:1992;533-539.
29. Steele A.D., et al. Interactions between opioid and chemokine receptors: heterologous desensitization. Cytokine Growth Factor Rev. 13:2002;209-222.
30. Donahoe R.M., Vlahov D. Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J. Neuroimmunol. 83:1998;77-87.
31. Peterson P.K., et al. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical μ-opioid receptor. Neuropharmacology. 38:1999;273-278.
32. Li Y., et al. Methadone enhances human immunodeficiency virus infection of human immune cells. J. Infect. Dis. 185:2002;118-122.
33. + lymphocytes. Biochem. Pharmacol. 61:2001;1145-1151.
34. + T cells and DOR-dependent suppression of HIV-1 expression. J. Immunol. 167:2001;1097-1102.
35. Szabo I., et al. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10276-10281.
36. Meucci O., et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14500-14505.
37. Asensio V.C., Campbell I.L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22:1999;504-512.
38. Fields R.D., Stevens-Graham B. New insights into neuron-glia communication. Science. 298:2002;556-562.
39. Inui A. Cytokines and sickness behavior: implications from knockout animal models. Trends Immunol. 22:2001;469-473.
40. Azuma Y., Ohura K. Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NK-κB DNA binding in THP-1 differentiated to macrophage-like cells. Scand. J. Immunol. 56:2002;260-269.
41. Peng X., et al. Morphine enhances interleukin-12 and the production of other proinflammatory cytokines in mouse peritoneal macrophages. J. Leukocyte Biol. 68:2000;723-728.
42. Pacifici R., et al. Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int. J. Immunopharmacol. 22:2000;603-614.
43. Gomez-Flores R., et al. Increased tumor necrosis factor-α and nitric oxide production by rat macrophages following in vitro stimulation and intravenous administration of the δ-opioid agonist SNC 80. Life Sci. 68:2001;2675-2684.